Concepedia

Publication | Closed Access

Assessment of JC virus DNA in blood and urine from natalizumab‐treated patients

102

Citations

15

References

2010

Year

Abstract

Measuring JCV DNA in blood or urine with currently available methods is unlikely to be useful for predicting PML risk in natalizumab-treated MS patients.

References

YearCitations

Page 1